News
The Ramon Areces Foundation funds UB and IDIBELL research projects
A project of Dr. Esteban Ballestar, from IDIBELL, funded by the Ramón Areces Foundation The Ramon Areces Foundation funded several research projects of UB and IDIBELL, through the Sixteenth Call of the Spanish National Competition. The act of delivery of the aid took place last June 27th at the headquarters of this organization in Madrid, […]
Bacterial translocation in cirrhotic patients: relationship with renal insufficiency and prognosis
IDIBELL Seminars. June 15, 2012. At the conference Dr José Such, from the Liver Unit of the General University Hospital of Alicante and CIBERehd, and specialized in bacterial translocation in cirrhotic patients, spoke of translocation and clinical effects. “The cirrhosis causes portal hypertension, which can lead to splanchnic vasodilation, all of which can cause the […]
Bellvitge researchers develop new method to reduce length of stay for patients with pneumonia
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have found a new safe and effective method to reduce the duration of intravenous antibiotic therapy and the length of hospital stay for patients with community-acquired pneumonia. This strategy would help to optimize the care of hospitalized patients with pneumonia and reduce the hospital costs. In Europe, […]
The Clinical Research Ethics Committee of Bellvitge announces its work
The Clinical Research Ethics Committee (CEIC) of the Bellvitge University Hospital was held on June 11th of an extraordinary session addressed to professionals interested in biomedical research, including basic and clinical researchers with the aim of introducing their work and exploring new avenues of communication with the scientific community.
The IDIBELL among the finest research institutions in Spain
The IDIBELL ranks fifth in a ranking of research institutions in Spain in a study published this week by the Fundación Conocimiento y Desarrollo (Knowledge and Development Foundation). Furthermore, the Catalan Institute of Oncology from Hospitalet, partner of IDIBELL, ranks second and, among universities, UB appears in first position. This study collects data from scientific […]
The epigenome of newborns and centenarians is different
An international study coordinated by Manel Esteller check how epigenetic marks are degrading over time. Since epigenetic lesions are reversible, it would be possible to develop drugs that increase the life span What happens in our cells after one hundred years? What is the difference at the molecular level between a newborn and a centenary? […]
Walk On Project” funds an IDIBELL project with almost 100,000 euros
The Walk on Project (WOP) nonprofit foundation, in collaboration with BBK Fundazioa, will fund with 98,000 euros a research project led by Dr. Aurora Pujol, ICREA research professor in Bellvitge Institute for Biomedical Research (IDIBELL), who is an expert in Human Genetics and Neurodegenerative Diseases. The project, entitled “Pharmacological strategies for the regeneration of myelin […]
Alfredo García, new Director of Bellvitge Hospital
Dr. Alfredo Garcia Diaz has been appointed managing director of the Bellvitge University Hospital and managing director of the South Metropolitan Territorial Management of the Catalan Institute of Health. Replaced in this role Dr. Xavier Corbella, who has been appointed manager of the Hospital Santa Creu i Sant Pau in Barcelona.
Study of 14-3-3 proteins in chemotherapy resistance
Certain proteins, such as 14-3-3, conserve their basic functions of cell cycle control in diverse organisms, from worms to humans. In a study led by Julián Cerón and Simó Schwartz Jr, researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Research Institute of Vall d’Hebron (VHIR) respectively, have described germ line functions of par-5, […]